Edition:
United States

Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

30.85PLN
8:58am EDT
Change (% chg)

1.85zł (+6.38%)
Prev Close
29.00zł
Open
29.60zł
Day's High
30.85zł
Day's Low
29.50zł
Volume
42,208
Avg. Vol
13,040
52-wk High
38.50zł
52-wk Low
27.88zł

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 46.37 28.26 32.60
P/E High - Last 5 Yrs. -- 41.40 47.30
P/E Low - Last 5 Yrs. -- 23.40 24.74
Beta -- 0.80 0.79
Price to Sales (TTM) 12.21 3.39 8.19
Price to Book (MRQ) 2.92 3.53 4.29
Price to Tangible Book (MRQ) 2.93 4.40 5.81
Price to Cash Flow (TTM) 28.21 19.28 21.74
% Owned Institutions -- 1.30 2.45

Dividends

  Company industry sector
Dividend Yield 0.59 1.80 1.67
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.63 4.06
Payout Ratio(TTM) 27.18 16.85 17.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -0.78 3.97 5.07
Sales (TTM) vs TTM 1 Yr. Ago -7.32 10.70 13.02
Sales - 5 Yr. Growth Rate -- 7.39 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 50.35 39.60 35.88
EPS (TTM) vs TTM 1 Yr. Ago -24.22 -- --
EPS - 5 Yr. Growth Rate -- 7.06 8.59
Capital Spending - 5 Yr. Growth Rate -- 8.05 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 11.14 2.55 2.53
Current Ratio (MRQ) 12.06 3.62 3.60
LT Debt to Equity (MRQ) 0.00 10.62 12.99
Total Debt to Equity (MRQ) 0.00 13.16 16.09
Interest Coverage (TTM) -- 40.51 35.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 62.54 55.42 55.04
Gross Margin - 5 Yr. Avg. -- 52.71 52.82
EBITD Margin (TTM) 44.07 -- --
EBITD - 5 Yr. Avg -- 18.50 15.90
Operating Margin (TTM) 27.09 14.61 0.15
Operating Margin - 5 Yr. Avg. -- 14.23 11.15
Pre-Tax Margin (TTM) 31.86 14.89 2.24
Pre-Tax Margin - 5 Yr. Avg. -- 14.51 11.36
Net Profit Margin (TTM) 26.33 11.30 -1.19
Net Profit Margin - 5 Yr. Avg. -- 10.80 7.65
Effective Tax Rate (TTM) 17.36 22.49 31.40
Effective Tax Rate - 5 Yr. Avg. -- 23.91 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) 394,462 834,642,710 724,115,471
Net Income/Employee (TTM) 103,851 97,014,216 84,106,404
Receivable Turnover (TTM) 3.97 5.60 5.75
Inventory Turnover (TTM) 2.05 2.52 3.59
Asset Turnover (TTM) 0.21 0.88 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 5.59 10.56 10.07
Return on Assets - 5 Yr. Avg. -- 11.65 11.08
Return on Investment (TTM) 5.78 13.20 12.74
Return on Investment - 5 Yr. Avg. -- 15.07 14.36
Return on Equity (TTM) 6.58 14.98 14.66
Return on Equity - 5 Yr. Avg. -- 16.32 15.72
  1 Year 3 Year 5 Year
Sales % -16.82 -- --
EPS (TTM) % -49.09 -- --
Dividend % 0.00 -- --
Note: Units in Millions of US Dollars

Performance for Celon Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.33 -1.32 92 9
13 Week -13.56 -6.76 65 11
26 Week -3.01 6.95 99 13
52 Week -12.57 -9.00 80 12
YTD -18.99 -11.02 58 10
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.51%
# of Holders: 13
Total Shares Held: 3,829,377
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.